{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:17:05Z","timestamp":1789078625125,"version":"build-2803163510"},"reference-count":36,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2020,3,10]]},"DOI":"10.3233\/jad-190818","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T12:37:28Z","timestamp":1579610248000},"page":"101-112","source":"Crossref","is-referenced-by-count":8,"title":["Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer\u2019s Disease with a Multi-Analytical Evaluation of Amyloid-\u03b2 Positron Emission Tomography"],"prefix":"10.1177","volume":"74","author":[{"given":"Leonie","family":"Beyer","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital of Munich, LMU, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Brendel","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital of Munich, LMU, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Scheiwein","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital of Munich, LMU, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Sauerbeck","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital of Munich, LMU, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisa","family":"Hosakawa","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kindai University, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Alberts","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Inselspital, University Hospital Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuangyu","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Inselspital, University Hospital Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bartenstein","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital of Munich, LMU, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kindai University, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Seibyl","sequence":"additional","affiliation":[{"name":"Invicro, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cumming","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Inselspital, University Hospital Bern, Bern, Switzerland"},{"name":"School of Psychology and Counseling and IHBI, Queensland University of Technology, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Rominger","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Inselspital, University Hospital Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-190818_ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-190818_ref2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: The IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-190818_ref3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-190818_ref4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-190818_ref5","doi-asserted-by":"crossref","unstructured":"Lee G , Nho K , Kang B , Sohn KA , Kim D (2019) Predicting Alzheimer\u2019s disease progression using multi-modal deep learning approach. Sci Rep 9, 1952.","DOI":"10.1038\/s41598-018-37769-z"},{"key":"10.3233\/JAD-190818_ref6","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3233\/JAD-190220","article-title":"18F-FDG is a superior indicator of cognitive performance compared to 18F-Florbetapir in Alzheimer\u2019s disease and mild cognitive impairment evaluation: A global quantitative analysis","volume":"70","author":"Khosravi","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-190818_ref7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: An updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-190818_ref8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MNM.0000000000000953","article-title":"Classification of amyloid PET images using novel features for early diagnosis of Alzheimer\u2019s disease and mild cognitive impairment conversion","volume":"40","author":"Yan","year":"2019","journal-title":"Nucl Med Commun"},{"key":"10.3233\/JAD-190818_ref9","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00259-013-2478-8","article-title":"[11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment","volume":"40","author":"Bruck","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-190818_ref10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"JAMA"},{"key":"10.3233\/JAD-190818_ref11","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/jamaneurol.2016.3751","article-title":"Assessment of the incremental diagnostic value of Florbetapir F 18 imaging in patients with cognitive impairment: The Incremental Diagnostic Value of Amyloid PET with [18F]-Florbetapir (INDIA-FBP) Study","volume":"73","author":"Boccardi","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-190818_ref12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/WAD.0b013e318279d02a","article-title":"Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline","volume":"27","author":"Grundman","year":"2013","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-190818_ref13","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1212\/WNL.0b013e318212015e","article-title":"Amyloid PET imaging in patients with mild cognitive impairment: A 2-year follow-up study","volume":"76","author":"Koivunen","year":"2011","journal-title":"Neurology"},{"key":"10.3233\/JAD-190818_ref14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.0b013e3181b23564","article-title":"Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study","volume":"73","author":"Okello","year":"2009","journal-title":"Neurology"},{"key":"10.3233\/JAD-190818_ref15","doi-asserted-by":"crossref","first-page":"101771","DOI":"10.1016\/j.nicl.2019.101771","article-title":"Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid-and (18)F-FDG-PET imaging","volume":"22","author":"Ottoy","year":"2019","journal-title":"Neuroimage Clin"},{"key":"10.3233\/JAD-190818_ref16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4306\/pi.2017.14.2.205","article-title":"Structural MRI and amyloid PET imaging for prediction of conversion to Alzheimer\u2019s disease in patients with mild cognitive impairment: A meta-analysis","volume":"14","author":"Seo","year":"2017","journal-title":"Psychiatry Investig"},{"key":"10.3233\/JAD-190818_ref17","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1007\/s00259-016-3462-x","article-title":"Feasibility and acceptance of simultaneous amyloid PET\/MRI","volume":"43","author":"Schutz","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-190818_ref18","doi-asserted-by":"crossref","first-page":"101846","DOI":"10.1016\/j.nicl.2019.101846","article-title":"Semi-quantification and grading of amyloid PET: A project of the European Alzheimer\u2019s Disease Consortium (EADC)","volume":"23","author":"Chincarini","year":"2019","journal-title":"Neuroimage Clin"},{"key":"10.3233\/JAD-190818_ref19","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jamaneurol.2015.1633","article-title":"Comparison of visual and quantitative Florbetapir F 18 positron emission tomography analysis in predicting mild cognitive impairment outcomes","volume":"72","author":"Schreiber","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-190818_ref20","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.2967\/jnumed.112.113654","article-title":"Longitudinal amyloid imaging using 11C-PiB: Methodologic considerations","volume":"54","author":"van Berckel","year":"2013","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-190818_ref21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.neuroimage.2014.11.055","article-title":"Improved longitudinal [(18)F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction","volume":"108","author":"Brendel","year":"2015","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-190818_ref22","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2967\/jnumed.114.149732","article-title":"Improved power for characterizing longitudinal amyloid-beta PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region","volume":"56","author":"Chen","year":"2015","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-190818_ref23","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2967\/jnumed.114.148981","article-title":"Measurement of longitudinal beta-amyloid change with 18F-florbetapir PET and standardized uptake value ratios","volume":"56","author":"Landau","year":"2015","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-190818_ref24","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1007\/s00259-017-3666-8","article-title":"Reference region selection and the association between the rate of amyloid accumulation over time and the ine amyloid burden","volume":"44","author":"Blautzik","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-190818_ref25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13195-016-0172-3","article-title":"Reference tissue normalization in longitudinal (18)F-florbetapir positron emission tomography of late mild cognitive impairment","volume":"8","author":"Shokouhi","year":"2016","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-190818_ref26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jalz.2012.10.007","article-title":"Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer\u2019s disease dementia, mild cognitive impairment, and normal aging.S","volume":"9","author":"Johnson","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-190818_ref27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jmri.21049","article-title":"The Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): MRI methods","volume":"27","author":"Jack","year":"2008","journal-title":"J Magn Reson Imaging"},{"key":"10.3233\/JAD-190818_ref28","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.neuroimage.2005.09.046","article-title":"Reliability in multi-site structural MRI studies: Effects of gradient non-linearity correction on phantom and human data","volume":"30","author":"Jovicich","year":"2006","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-190818_ref29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1109\/42.668698","article-title":"A nonparametric method for automatic correction of intensity nonuniformity in MRI data","volume":"17","author":"Sled","year":"1998","journal-title":"IEEE Trans Med Imaging"},{"key":"10.3233\/JAD-190818_ref30","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuroimage.2005.02.018","article-title":"Unified segmentation","volume":"26","author":"Ashburner","year":"2005","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-190818_ref31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hbm.10123","article-title":"Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe","volume":"19","author":"Hammers","year":"2003","journal-title":"Hum Brain Mapp"},{"key":"10.3233\/JAD-190818_ref32","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.neuroimage.2014.11.055","article-title":"Improved longitudinal [(18)F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction","volume":"108","author":"Brendel","year":"2015","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-190818_ref33","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.3233\/JAD-190818_ref34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1474-4422(17)30159-X","article-title":"Strategic roadmap for an early diagnosis of Alzheimer\u2019s disease based on biomarkers","volume":"16","author":"Frisoni","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-190818_ref35","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neurobiolaging.2016.07.012","article-title":"Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer\u2019s disease in the context of a structured 5-phase development framework","volume":"52","author":"Chiotis","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-190818_ref36","doi-asserted-by":"crossref","first-page":"20181020","DOI":"10.1259\/bjr.20181020","article-title":"Optimisation and usefulness of quantitative analysis of (18)F-florbetapir PET","volume":"92","author":"Fakhry-Darian","year":"2019","journal-title":"Br J Radiol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-190818","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:36Z","timestamp":1777370856000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-190818"}},"subtitle":[],"editor":[{"given":"Valentina","family":"Bessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,3,10]]},"references-count":36,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-190818","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,10]]}}}